Cargando…
Management of Acute Pancreatitis Associated With Checkpoint Inhibitors
Pancreatitis is a rare immune-related adverse event (irAE) associated with the use of immune checkpoint inhibitors (ICIs). It is more often associated with combined immunotherapy than by any single agent. Early signs of pancreatitis may only include elevation of lipase and amylase. Additional sympto...
Autores principales: | Rogers, Barbara Barnes, Cuddahy, Terri, Zawislak, Carolyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517772/ https://www.ncbi.nlm.nih.gov/pubmed/33542849 http://dx.doi.org/10.6004/jadpro.2020.11.1.3 |
Ejemplares similares
-
Myasthenia Gravis: A Rare Neurologic Complication of Immune Checkpoint Inhibitor Therapy
por: Shames, Yelena, et al.
Publicado: (2022) -
Case report of elevation of high-sensitivity cardiac troponin T in the absence of cardiac involvement in immune checkpoint inhibitor-associated myositis
por: Ruperti-Repilado, Francisco Javier, et al.
Publicado: (2022) -
Checkpoint inhibitor-induced myocarditis and myasthenia gravis in a recurrent/metastatic thymic carcinoma patient: a case report
por: Szuchan, Charles, et al.
Publicado: (2020) -
Prevention and Management of Acute Kidney Injury
por: Harty, John
Publicado: (2014) -
Management of Adverse Events Associated With Tyrosine Kinase Inhibitor Use in Adult Patients With Chronic Myeloid Leukemia in Chronic Phase: An Advanced Practice Perspective
por: Bauer, Stephanie, et al.
Publicado: (2021)